108 related articles for article (PubMed ID: 1831040)
1. Intralesional monoclonal antibodies effective against melanoma.
Oncology (Williston Park); 1991 Apr; 5(4):56. PubMed ID: 1831040
[No Abstract] [Full Text] [Related]
2. [Immunohistological study of the mechanism of cytotoxic effect against cutaneous metastatic malignant melanoma by intralesional injection with anti-monosialoganglioside mouse monoclonal antibody (MAb 202)].
Ota T; Imamura T; Hamanaka S; Nishioka K; Tai T; Kawashima I; Irie RF; Asagami C
Nihon Hifuka Gakkai Zasshi; 1988 Aug; 98(9):913-22. PubMed ID: 3244169
[No Abstract] [Full Text] [Related]
3. [Cancer therapy with monoclonal antibody].
Irie RF; Hachida M
Tanpakushitsu Kakusan Koso; 1986 Nov; 31(14):1501-10. PubMed ID: 3544072
[No Abstract] [Full Text] [Related]
4. [Active specific immunotherapy of cancer using anti-idiotypic monoclonal antibodies].
Castello G; D'Alessio V
Clin Ter; 1991 May; 137(3):155-67. PubMed ID: 1831084
[TBL] [Abstract][Full Text] [Related]
5. Immunology and immunotherapy of human malignant melanoma.
Bystryn JC
Dermatol Clin; 1985 Apr; 3(2):327-34. PubMed ID: 2937585
[TBL] [Abstract][Full Text] [Related]
6. Preliminary experiences of intralesional immunotherapy in cutaneous metastatic melanoma.
Ridolfi L; Ridolfi R
Hepatogastroenterology; 2002; 49(44):335-9. PubMed ID: 11995445
[TBL] [Abstract][Full Text] [Related]
7. [Present status and problems in the therapy of malignant melanoma].
Nakayama J
Fukuoka Igaku Zasshi; 1995 Jan; 86(1):1-5. PubMed ID: 7698716
[No Abstract] [Full Text] [Related]
8. Combination immunotherapy breakthrough for melanoma.
Brower V
Lancet Oncol; 2015 Jul; 16(7):e318. PubMed ID: 26062775
[No Abstract] [Full Text] [Related]
9. Immunotherapy of melanoma.
Chapman PB
Cancer Chemother Biol Response Modif; 2002; 20():371-83. PubMed ID: 12703215
[No Abstract] [Full Text] [Related]
10. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
11. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
12. [Comment on the contribution by G. Fierlbeck, B. d'Hoedt, W. Stroebel, H. Stutte, O. Bogenschütz and G. Rassner. Intralesional therapy of melanoma metastases with recombinant interferon-beta].
Kölmel KF; Abel U
Hautarzt; 1993 May; 44(5):329-30. PubMed ID: 8320124
[No Abstract] [Full Text] [Related]
13. Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy.
Bodey B; Kaiser HE; Goldfarb RH
Anticancer Res; 1996; 16(1):517-31. PubMed ID: 8615665
[TBL] [Abstract][Full Text] [Related]
14. [Clinical trial of anti-idiotypic monoclonal antibodies in advanced melanoma].
Kageshita T; Hirai S; Ono T
Gan To Kagaku Ryoho; 1994 Feb; 21(2):163-9. PubMed ID: 8311486
[TBL] [Abstract][Full Text] [Related]
15. [Medical therapy of malignant melanoma].
Mini E; Periti P
Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710
[No Abstract] [Full Text] [Related]
16. Anticytotoxic T lymphocyte-associated antigen 4 treatment--can melanoma be cured at the expense of autoimmune disorders?
Lejeune FJ
Melanoma Res; 2006 Oct; 16(5):377-8. PubMed ID: 17013085
[No Abstract] [Full Text] [Related]
17. Biologic therapy.
Edington H; Agarwala S; Kirkwood JM
Clin Plast Surg; 2000 Oct; 27(4):643-65. PubMed ID: 11039895
[TBL] [Abstract][Full Text] [Related]
18. Melanoma and immunotherapy.
Eggermont AM; Schadendorf D
Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy and cancer: the role of monoclonal antibodies].
Dumontet C
J Chir (Paris); 1989 Dec; 126(12):682-6. PubMed ID: 2695534
[TBL] [Abstract][Full Text] [Related]
20. [Clinical application of monoclonal antibodies to human malignant melanoma-associated antigens].
Kageshita T; Ishihara K
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1744-8. PubMed ID: 3899015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]